Editas Medicine, Inc. - Common Stock — Cash Flow (NASDAQ:EDIT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -179.84 M-163.8 M-177.35 M-132.18 M-210.28 M-165.24 M -119.86 M Cash from investing activities -140.52 M-54.47 M114.07 M-3.73 M162.15 M138.67 M 9.89 M Cash from financing activities 224.12 M282.11 M1.28 M118.04 M56.03 M40.47 M 152.03 M Free cash flow -179.84 M-163.8 M-177.35 M-132.18 M-210.28 M-165.85 M -120.55 M

News

4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains

Is Editas Medicine (EDIT) Outperforming Other Medical Stocks This Year?

EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus

Editas Medicine (EDIT) Reports Q2 Loss, Beats Revenue Estimates

Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates

Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?

Editas Medicine: Resetting Pipeline Just To Be Second To Market Again (NASDAQ:EDIT)

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Company News for May 6, 2026

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now